New GlyT2 blocker relieves chronic neuropathic pain without major side effects
Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited benefit and being over-reliant on opioids. Researchers at Rensselaer Polytechnic Institute (RPI), along with collaborators from the University of Sydney and the University of Cop
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · AU
- [ENERGY] Lessons from Australia for scaling rooftop solar and home batteries
- [CONFLICT] Can't get your HRT patches? What to do and what to avoid
- [CONFLICT] Australian map from 1920 showing immigration from Europe to the rest of the world
- [SPORTS] Australia Football demands reversal of Melbourne World Cup watch party ban
- [HEALTH] Antisemitic manosphere streamer Sneako kicked out of, banned from Australia
- [PROTEST] Coalition considers plan to slash net overseas immigration by nearly half its current rate, leaked documents reveal